Reappraisal of the intravenous glucose tolerance index for a simple assessment of insulin sensitivity in mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 5, 2009, Pages

  Pacini, Giovanni ^a   Ahrén, Maria ^b   Ahrén, Bo ^b  

^a CNR   (Italy)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Animal model; Glucagon like peptide 1; Glucose effectiveness; Insulin resistance; Intravenous glucose tolerance test; Pituitary adenylate cyclase activating polypeptide

Indexed keywords

GLUCOSE; INCRETIN; INSULIN; NEUROPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLUCOSE CLAMP TECHNIQUE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MATHEMATICAL MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VALIDATION STUDY;

ANIMALS; BLOOD GLUCOSE; GALANIN; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; INJECTIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; LINOLEIC ACID; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MODELS, ANIMAL; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE;

EID: 66149096190     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.90575.2008     Document Type: Article

References (28)

1. Ader M, Pacini G, Yang YJ, Bergman RN. Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements. Diabetes 34: 1092-1103, 1985.
2. Ahrén B, Havel PJ, Pacini G, Cianflone K. Acylation stimulating protein stimulates insulin secretion. Int J Obesity 27: 1037-1043, 2003.
3. Ahrén B, Pacini G, Wynick D, Wierup N, Sundler F. Loss-of-function mutation of the galanin gene is associated with perturbed islet function in mice. Endocrinology 145: 3190-3196, 2004.
4. Ahrén B, Pacini G. Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. J Clin Endocrinol Metab 83: 3350-3356, 1998.
5. Ahrén B, Pacini G. Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity and glucose effectiveness in mice. Am J Physiol Endocrinol Metab 277: E996-E1004, 1999.
6. Ahrén B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 150: 97-104, 2004.
7. Ahrén B, Pacini G. Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. Am J Physiol Endocrinol Metab 283: E738-E744, 2002.
8. Ayala JE, Bracy GP, McGuinness OP, Wasserman DH. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55: 390-397, 2006.
9. Bergman RN. Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 38: 1512-1527, 1989.
10. Best JD, Kahn SE, Ader M, Watanabe RM, Ni T-C, Bergman RN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19: 1018-1030, 1996.
11. Filipsson K, Pacini G, Scheurink AJW, Ahrén B. PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice. Am J Physiol Endocrinol Metab 274: E834-E842, 1998.
12. Finegood DT, Tzur D. Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal model method. Am J Physiol Endocrinol Metab 271: E485-E495, 1996.
13. Galvin P, Ward G, Walters J, Pestell R, Koschmann M, Vaag A, Martin I, Best JD, Alford F. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med 9: 921-928, 1992.
14. Hvidberg A, Toft-Nielsen M, Hilsted J, Orskov C, Holst JJ. Effect of glucagon-like peptide-1 (proglucagon 78-107 amide) on hepatic glucose production in healthy man. Metabolism 43: 104-108, 1994.
15. Kahn SE, Klaff LJ, Schwartz MW, Beard JC, Bergman RN, Taborsky J Jr. Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J Clin Endocrinol Metab 71: 994-1002, 1990.
16. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr. The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43: 587-592, 1994.
17. Manly BFJ. Randomization and Monte Carlo Methods in Biology. London: Chapman & Hall, 1991, p. 28-30.
18. Mari A. Assessment of insulin sensitivity with minimal model: role of model assumptions. Am J Physiol Endocrinol Metab 272: E925-E934, 1997.
19. Mari A, Ahrén B, Pacini G. Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care 8: 529-533, 2005.
20. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294: E15-E26, 2008.
21. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23: 113-122, 1986.
22. Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and β-cell function. Best Pract Res Clin Endocrinol Metab 17: 305-322, 2003.
23. Pacini G, Thomaseth K, Ahrén B. Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. Am J Physiol Endocrinol Metab 281: E693-E703, 2001.
24. Pacini G, Tonolo G, Sambataro M, Maioli M, Ciccarese M, Brocco E, Avogaro A, Nosadini R. Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. Am J Physiol Endocrinol Metab 274: E592-E599, 1998.
25. Quon MJ, Cochran C, Taylor SI, Eastman RC. Non-insulin-mediated glucose disappearance in subjects with IDDM. Diabetes 43: 890-896, 1994.
26. Sörhede-Winzell M, Pacini G, Ahrén B. Insulin secretion after dietary supplementation of conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin resistant mice. Am J Physiol Endocrinol Metab 290: E347-E354, 2006.
27. G, minimal model parameters, and early insulin response. In: The Minimal Model Approach and Determinants of Glucose Tolerance, edited by Bergman RN and Lovejoy JC. Baton Rouge, LA: Louisiana State University Press, 1997, p. 142-158.
28. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study. Lancet 359: 824-830, 2002.